Comments to FDA: Probiotics Labeling Share page: Docket Number: FDA-2011-D-0376 Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics). Download Document Issues: Dietary Supplements Probiotics Other Issues Labeling Related Posts Teaser Image: Using Gen AI to Uncover Insights Teaser Image Content Category: Sales & Marketing Using Gen AI to Uncover Insights Into the Dietary Supplements Category Executive Summary of Findings: Dietary Supplement Regulatory Modernization May 7, 2025 Letter Letter Regarding Office of Management & Budget Request for Information: Deregulation May 12, 2025